Pinnacle Bancorp’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$77.9K Sell
1,242
-189
-13% -$15.1K 0.02% 367
2025
Q4
$136K Sell
1,431
-201
-12% -$19.7K 0.04% 283
2025
Q3
$159K Buy
1,632
+284
+21% +$29.4K 0.05% 258
2025
Q2
$145K Buy
1,348
+93
+7% +$9.41K 0.04% 270
2025
Q1
$127K Buy
1,255
+211
+20% +$21.2K 0.04% 275
2024
Q4
$93.3K Hold
1,044
0.03% 318
2024
Q3
$87.5K Hold
1,044
0.02% 318
2024
Q2
$80.4K Hold
1,044
0.02% 316
2024
Q1
$71.5K Hold
1,044
0.02% 341
2023
Q4
$60.4K Sell
1,044
-11
-1% -$587 0.02% 357
2023
Q3
$55.7K Hold
1,055
0.02% 350
2023
Q2
$57.1K Sell
1,055
-112
-10% -$5.85K 0.02% 350
2023
Q1
$58.4K Buy
1,167
+291
+33% +$13.7K 0.02% 339
2022
Q4
$41K Hold
876
0.02% 359
2022
Q3
$34K Hold
876
0.01% 373
2022
Q2
$33K Hold
876
0.01% 386
2022
Q1
$39K Hold
876
0.01% 376
2021
Q4
$37K Hold
876
0.01% 389
2021
Q3
$38K Buy
876
+167
+24% +$7.39K 0.02% 379
2021
Q2
$30K Hold
709
0.01% 425
2021
Q1
$27K Buy
+709
New +$26.8K 0.01% 434
2019
Q4
Sell
-65
Closed -$3K 648
2019
Q3
$3K Buy
+65
New +$2.75K ﹤0.01% 663

Other funds holding BSX

Pinnacle Bancorp's BSX Position: Q1 2026 in Review

Pinnacle Bancorp reduced its Boston Scientific (BSX) stake by 13% in Q1 2026, selling an estimated $15.1K and leaving 1,242 shares worth $77.9K. The position accounts for 0.02% of the portfolio, ranked #367.

Pinnacle Bancorp first reported a position in BSX in Q3 2019 and has held it in 22 quarters since. The position peaked at $159K in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Pinnacle Bancorp held 1,242 shares of Boston Scientific worth $77.9K as of Q1 2026.
  • Pinnacle Bancorp sold 189 Boston Scientific shares in Q1 2026, an estimated $15.1K.
  • Boston Scientific made up 0.02% of Pinnacle Bancorp's portfolio in Q1 2026, its #367 holding.
  • Pinnacle Bancorp first reported a position in Boston Scientific in Q3 2019 and has held it in 22 quarters since.
  • Pinnacle Bancorp's Boston Scientific position peaked at $159K in Q3 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Pinnacle Bancorp's 13F filing for Q1 2026, filed 22 Apr 2026.